Form 4: Ventyx Biosciences CEO Mohan Raju Reports Stock Transaction
SEC Form 4 Filing
CEO Mohan Raju reports the vesting of restricted stock units into common stock of Ventyx Biosciences.
Summary
- On March 28, 2024, Mohan Raju, CEO and President of Ventyx Biosciences, Inc., reported a transaction involving restricted stock units (RSUs).
- 11,843 RSUs vested and were converted into common stock at a price of $0.
- Following the transaction, Raju directly owns 1,582,562 shares of Ventyx Biosciences common stock and 35,532 restricted stock units.
- The RSUs vest over four years, with 25% vesting on each annual anniversary of March 28, 2023.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by an insider, neither inherently positive nor negative.
Industry Context
This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 03/28/2023 | RSU Vesting Commencement Date |
| 03/28/2024 | Date of transaction: vesting of RSUs |
| 03/29/2024 | Date of report filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.